COMMUNIQUÉS West-GlobeNewswire

vTv Therapeutics Announces FDA Submission for First Phase 3 Study of Cadisegliatin in Patients with Type 1 Diabetes
04/03/2024
HIGH POINT, N.C., March 04, 2024 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical stage biopharmaceutical company focused on the development of cadisegliatin (TTP399) as an adjunctive therapy to [...]
Belite Bio to Participate in the Leerink Partners Global Biopharma Conference
04/03/2024
SAN DIEGO, March 04, 2024 (GLOBE NEWSWIRE) -- Belite Bio, Inc. (NASDAQ: BLTE), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases [...]
MIMEDX Announces Appointment of Two New Independent Directors
04/03/2024
MARIETTA, Ga., March 04, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced the appointments of Tiffany Olson and Dorothy Puhy to its Board of Directors, effective as [...]
CytomX Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024
04/03/2024
SOUTH SAN FRANCISCO, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activated, localized biologics, today announced that it will report full [...]
Arcutis Announces Acceptance of Late Breaking Abstract in Atopic Dermatitis Among Five New Topical Roflumilast Data Being Presented at the American Academy of Dermatology Annual Meeting
04/03/2024
Late breaking sessions to highlight new data from the INTEGUMENT-PED trial evaluating roflumilast cream 0.05% in children ages 2-5 with atopic dermatitis New patient-reported outcomes including pruritus data from two [...]
Orion Corporation: Managers’ transactions – Olli Huotari
04/03/2024
ORION CORPORATION MANAGERS’ TRANSACTIONS 4 MARCH 2024 at 13.00 EET Orion Corporation: Managers’ transactions – Olli Huotari Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No [...]
Orion Corporation: Managers’ transactions – Satu Ahomäki
04/03/2024
ORION CORPORATION MANAGERS’ TRANSACTIONS 4 MARCH 2024 at 13.00 EET Orion Corporation: Managers’ transactions – Satu Ahomäki Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No [...]
Orion Corporation: Managers’ transactions – Liisa Hurme
04/03/2024
ORION CORPORATION MANAGERS’ TRANSACTIONS 4 MARCH 2024 at 13.00 EET Orion Corporation: Managers’ transactions – Liisa Hurme Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No [...]
The Ensign Group Acquires Skilled Nursing Facility in Kansas
04/03/2024
SAN JUAN CAPISTRANO, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign TM group of companies, which invest in and provide skilled nursing and senior [...]
The Ensign Group Acquires Two Skilled Nursing Facilities in Colorado
04/03/2024
SAN JUAN CAPISTRANO, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living [...]
Orion Corporation: Managers’ transactions – Jari Karlson
04/03/2024
ORION CORPORATION MANAGERS’ TRANSACTIONS 4 MARCH 2024 at 13.00 EET Orion Corporation: Managers’ transactions – Jari Karlson Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No [...]
Akero Therapeutics Reports Statistically Significant Histological Improvements at Week 96 in Phase 2b HARMONY Study
04/03/2024
50mg (75%, p<0.001) and 28mg (46%, p=0.07) EFX groups demonstrated ≥1 stage improvement in fibrosis without worsening of MASH, approximately three- and two-fold the placebo rate (24%) 50mg (36%, p<0.01) and 28mg ( [...]
Orion Corporation: Managers’ transactions – Juhani Kankaanpää
04/03/2024
ORION CORPORATION MANAGERS’ TRANSACTIONS 4 MARCH 2024 at 13.00 EET Orion Corporation: Managers’ transactions – Juhani Kankaanpää Orion Corporation has received the following disclosure under Market Abuse Regulation (EU [...]
Orion Corporation: Managers’ transactions – Virve Laitinen
04/03/2024
ORION CORPORATION MANAGERS’ TRANSACTIONS 4 MARCH 2024 at 13.00 EET Orion Corporation: Managers’ transactions – Virve Laitinen Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No [...]
Orion Corporation: Managers’ transactions – Niclas Lindstedt
04/03/2024
ORION CORPORATION MANAGERS’ TRANSACTIONS 4 MARCH 2024 at 13.00 EET Orion Corporation: Managers’ transactions – Niclas Lindstedt Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) [...]
RadNet, Inc. to Present at the Raymond James 45th Annual Institutional Investors Conference Today, March 4th, 2024
04/03/2024
LOS ANGELES, March 04, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated [...]
Orion Corporation: Managers’ transactions – Hao Pan
04/03/2024
ORION CORPORATION MANAGERS’ TRANSACTIONS 4 MARCH 2024 at 13.00 EET Orion Corporation: Managers’ transactions – Hao Pan Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/ [...]
Orion Corporation: Managers’ transactions – Outi Vaarala
04/03/2024
ORION CORPORATION MANAGERS’ TRANSACTIONS 4 MARCH 2024 at 13.00 EET Orion Corporation: Managers’ transactions – Outi Vaarala Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No [...]
CytoMed Therapeutics Limited Announces Research Collaboration with Singapore Sengkang General Hospital to Advance Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Diseases and Repair
04/03/2024
CytoMed diversifies into regenerative medicine SINGAPORE, March 04, 2024 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based biopharmaceutical company focused on [...]

Pages